Cardinal Health, US14149Y1082

Cardinal Health stock: Argus lifts target to $309

Published on 11/16/2026 at 16:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cardinal Health stock gets a higher Argus target as the analyst keeps a Buy rating. The move adds a new investor reference after the company's stronger fiscal outlook.

Analyst view and trading context

  • Argus retained its Buy rating while raising its target.
  • The target change came after Cardinal Health reported fiscal first-quarter results and a higher full-year outlook.
Cardinal Health, US14149Y1082, Illustration mit AI erstellt.

Argus Research raised its Cardinal Health price target from 264 to 309 US dollars on Thursday, November 12, while maintaining a Buy rating, according to Aries. The analyst action gives investors a new reference point after Cardinal Health's fiscal first-quarter results and higher full-year outlook.

What the target change signals

Aries lists Argus as the latest rating action in its analyst table. The firm kept its Buy view while lifting the target, extending a constructive run of post-results target changes that also includes actions from other Wall Street firms.

The target revision does not change Cardinal Health's operating guidance. It adds an external valuation view to the company's existing earnings and outlook framework, leaving execution in pharmaceutical distribution, specialty services and other businesses as key factors for investors.

Monday trading context

Cardinal Health stock traded at 258.10 euros on Lang & Schwarz at 16:08 CET on Monday, November 16.

Cardinal Health at a glance

  • Company: Cardinal Health
  • ISIN: US14149Y1082
  • Ticker: CAH
  • Home exchange: NYSE
  • Quote: 258.10 euros on Lang & Schwarz at 16:08 CET on Monday, November 16, 2026

US equity market context is available in Current market reports.

More news and analyses on Cardinal Health stock

Disclaimer...
en | US14149Y1082 | CARDINAL HEALTH | boerse | 70521491 | bgmi